Osaka, Japan

Ryuichiro Ebi

This inventor holds 25 USPTO granted patents and 3 published patent applications and 14 EPO patents, primarily in Cell Analysis Technology. Top assignees: Sysmex Corporation, Matsushita Electric Industrial Co., Ltd., Panasonic Corporation. Active years: 2002-2022.

USPTO Granted Patents = 25 

% Patents Active = 76.0

 

Average Co-Inventor Count = 2.7

ph-index = 6

Forward Citations = 122(Granted Patents)


Location History:

  • Neyagawa, JP (2002)
  • Osaka, JP (2003 - 2017)
  • Kobe, JP (2014 - 2022)

Company Filing History:


Years Active: 2002-2022

Loading Chart...
Loading Chart...
Areas of Expertise:
Cell Analyzer
Sample Preparation
Cancer Detection
Quality Control
Cell Processing
Urine Sample Analysis
Cervical Cancer
Filter Member
Reaction Container
Sample Screening
Discriminating Cells
Battery Technology
25 patents (USPTO):Explore Patents

Title: The Innovative Mind of Ryuichiro Ebi

Introduction: Ryuichiro Ebi, a visionary inventor hailing from Osaka, Japan, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ryuichiro Ebi's latest patents include cutting-edge advancements in artificial intelligence, robotics, and sustainable energy solutions, solidifying his position as a pioneer in the industry.

Career Highlights: With a career spanning over two decades, Ebi has consistently pushed the boundaries of what is possible, with his inventions revolutionizing various sectors, from healthcare to transportation.

Collaborations: Throughout his career, Ryuichiro Ebi has collaborated with leading research institutions, universities, and tech companies worldwide, fostering a culture of innovation and knowledge-sharing.

Conclusion: Ryuichiro Ebi's relentless pursuit of innovation and his passion for creating a better future through technology make him a true trailblazer in the world of inventions. His impact will undoubtedly continue to inspire generations to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…